Carnitine Palmitoyl Transferase 1, Muscle, Mouse, Control Peptide (CPT1-M)

Control peptide for C1385-40 (antiserum) and C1385-45 (affinity purified antibody). Synthetic peptide consisting of 13aa sequence mapping near the C-terminus of mouse CPT1-M. No significant sequence homology is seen with LCPT-1, CPT-2 or any other protein. Species crossreactivity: Rat: 92%; human: 69%.\n\nIn cells and organisms, the excess of metabolic fuel is converted into fatty acids in cytosol and oxidized later in mitochondria to generate ATP and acetyl-CoA. In fatty acid synthesis, catalytic formation of malonyl-CoA (precursor for long-chain fatty acyl-CoA, LCFA-CoA) from acetyl-CoA by Acetyl-CoA carboxylase (ACC-1). Activities of ACC-1 and ACC-2 are regulated by their phosphorylation by 5'-AMP-activated protein kinase (AMPK). Diabetes deranges AMPK master-switch, represses the ACC-1 gene-expression and stimulates excessive fatty acid oxidation which in turn interferes with glucose metabolism. Cytosolic LCFA-CoA is converted into acyl-carnitine at mitochondrial membrane surface by carnitine palmitoyl transferase-1 (CPT-1) followed by the reconversion of the latter into LCFA-CoA by CPT-2 in the mitochondrial matrix. Mitochondrial oxidation of LC-FCA is initiated by the sequential action of CPT-1, which is located in the outer membrane, and CPT-2, which is located in the inner membrane together with a carnitine-acylcarnitine translocase. CPT-1 liver or CPT1A or LCPT-1 (mouse 764aa, rat 773aa, human 773aa, ~88kD, chromosome 11q13) is malonyl-CoA-sensitive enzyme localized on the outer surface of mitochondrial 'contact sites'. It catalyzes the conversion of long-chain acyl-CoA into acyl-carnitine, committing the acyl moiety to intramitochondrial oxidation. It is predominantly expressed in kidney, liver and in trace amounts in heart. The 'muscle' isoform CPT1B or CPT1M or MCPT-1 (mouse/rat/human 772aa, chromosome 22q13.3) is found in heart, skeletal muscle, adipose tissue and brain. The aa sequences of the two isoforms are ~61% identical.\n\nApplications: \nSuitable for use in ELISA and Antibody Blocking. Not suitable for use in Western Blot due to low molecular weight. Other applications not tested.\n\nRecommended Dilution:\nELISA: 50-100ng of control peptide/well.\nAntibody Blocking: 5-10ug per 1ul C1385-40 (antiserum) or per 1ugC1385-45 (affinity purified antibody).\nOptimal dilutions to be determined by the researcher.\n\nStorage and Stability:\nMay be stored at 4 degrees C for short-term only. For long-term storage, store at -20 degrees C. Aliquots are stable for at least 6 months at -20 degrees C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts